Holen Sie sich die Stockscreener-App
8.42
6.13%
-0.55
Handel nachbörslich:
8.42
Finanzdaten der Olema Pharmaceuticals Inc-Aktie (OLMA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
37.25%
47.86
|
34.87 | 36.77 | 37.62 | 33.53 |
| Operating Income/Loss |
37.25%
-47.86
|
-34.87 | -36.77 | -37.62 | -33.53 |
| Nonoperating Income/Loss |
9.01%
4.08
|
4.484 | 3.201 | 3.066 | 3.148 |
| Income/Loss From Continuing Operations Before Tax |
44.08%
-43.78
|
-30.39 | -33.56 | -34.55 | -30.38 |
| Income/Loss From Continuing Operations After Tax |
44.08%
-43.78
|
-30.39 | -33.57 | -34.55 | -30.38 |
|
Net Income/Loss
|
44.08%
-43.78
|
-30.39 | -33.57 | -34.55 | -30.38 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.08%
85.50
|
85.43 | 5.5494 | 57.26 | 56.28 |
| Diluted Average Shares |
0.08%
85.50
|
85.43 | 5.5494 | 57.26 | 56.28 |
| Basic Earnings Per Share |
41.67%
-0.51
|
-0.36 | -0.40 | -0.60 | -0.54 |
| Diluted Earnings Per Share |
41.67%
-0.51
|
-0.36 | -0.40 | -0.60 | -0.54 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):